Tonix Pharmaceuticals stock halted ahead of FDA approval news
Sweetgreen , Inc. (NYSE:SG) Chief Financial Officer Mitch Reback recently executed a stock transaction involving the sale of 4,000 shares of Class A Common Stock. The shares were sold at a price of $21.07 each, resulting in a total transaction value of $84,280. This sale was carried out on April 15, 2025, amid a challenging period for the stock, which has declined nearly 46% over the past six months. According to InvestingPro analysis, the stock appears overvalued at current levels, with several indicators suggesting continued volatility ahead.
In addition to the sale, Reback also exercised stock options to acquire 4,000 shares at a price of $4.78 per share. Following these transactions, Reback holds a total of 344,509 shares directly. The sale was conducted under a 10b5-1 trading plan established on September 9, 2024, which allows company insiders to set up a predetermined plan to sell shares based on certain conditions. While the company maintains a healthy current ratio of 2.02 and operates with moderate debt, InvestingPro data reveals that six analysts have recently revised their earnings expectations downward for the upcoming period. For deeper insights into insider trading patterns and comprehensive financial analysis, investors can access the detailed Pro Research Report available on InvestingPro.
In other recent news, Sweetgreen Inc. reported its fourth-quarter 2024 earnings, which fell short of analyst expectations. The company recorded an earnings per share (EPS) of -$0.25, compared to a forecast of -$0.20, and generated revenue of $160.9 million, slightly below the anticipated $163.4 million. Despite the earnings miss, Sweetgreen achieved a 15% increase in full-year sales, reaching $676.8 million, and reported its first full year of positive adjusted EBITDA at $18.7 million. Analysts from Piper Sandler reaffirmed a Neutral rating with a $27 price target, while UBS revised its price target down to $35 from $45, maintaining a Buy rating. TD Cowen also lowered its price target to $33, citing a slowdown in same-store sales but upheld a Buy rating, acknowledging the company’s growth potential through new store openings and kitchen automation. RBC Capital reduced its price target to $30 from $45, maintaining an Outperform rating, highlighting Sweetgreen’s strategic initiatives like menu enhancements and loyalty programs to boost sales. Despite the challenges, Sweetgreen’s management remains optimistic about long-term growth, planning to open at least 40 new locations in 2025, with a focus on the Infinite Kitchen concept.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.